Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
71
SGHT Quote, Financials, Valuation and Earnings
Last price:
$7.45
Seasonality move
:
-6.3%
Day range:
$7.39 - $7.68
52-week range:
$2.03 - $9.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.07x
P/B ratio:
6.14x
Volume:
197.7K
Avg. volume:
273.2K
1-year change:
119.71%
Market cap:
$395M
Revenue:
$79.9M
EPS (TTM):
-$0.90
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SGHT
Sight Sciences, Inc.
|
$20.2M | -$0.16 | 5.73% | -31.35% | $8.68 |
|
ADGM
Adagio Medical Holdings, Inc.
|
-- | -$0.31 | -100% | -91.79% | $4.00 |
|
INBS
Intelligent Bio Solutions, Inc.
|
$1.4M | -- | 160.36% | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18.5M | -$0.03 | -60.4% | -72.53% | $1.65 |
|
LNSR
LENSAR, Inc.
|
$20.5M | -$0.09 | 30.98% | -90.51% | $15.00 |
|
MOVE
Movano, Inc.
|
$3.4M | -$7.10 | 76.06% | -41.21% | $30.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SGHT
Sight Sciences, Inc.
|
$7.47 | $8.68 | $395M | -- | $0.00 | 0% | 5.07x |
|
ADGM
Adagio Medical Holdings, Inc.
|
$0.99 | $4.00 | $21M | 218.00x | $0.00 | 0% | 110.91x |
|
INBS
Intelligent Bio Solutions, Inc.
|
$10.70 | -- | $10.3M | -- | $0.00 | 0% | 21.27x |
|
LAB
Standard BioTools, Inc.
|
$1.27 | $1.65 | $488.4M | -- | $0.00 | 0% | 3.74x |
|
LNSR
LENSAR, Inc.
|
$11.45 | $15.00 | $136.8M | -- | $0.00 | 0% | 2.29x |
|
MOVE
Movano, Inc.
|
$7.78 | $30.00 | $6.5M | -- | $0.00 | 0% | 11.77x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SGHT
Sight Sciences, Inc.
|
38.76% | 0.678 | 22.54% | 8.65x |
|
ADGM
Adagio Medical Holdings, Inc.
|
106.35% | 0.022 | 73.62% | 0.48x |
|
INBS
Intelligent Bio Solutions, Inc.
|
35.02% | 2.237 | 21.48% | 0.47x |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.680 | 5.49% | 1.93x |
|
LNSR
LENSAR, Inc.
|
-31.16% | -0.941 | 1.79% | 0.65x |
|
MOVE
Movano, Inc.
|
212.35% | 3.110 | 67.05% | 0.29x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SGHT
Sight Sciences, Inc.
|
$17.2M | -$7.9M | -38.96% | -58.45% | -39.71% | -$8.9M |
|
ADGM
Adagio Medical Holdings, Inc.
|
-$531K | -$5.7M | -193.23% | -340.49% | -- | -$3.5M |
|
INBS
Intelligent Bio Solutions, Inc.
|
$214.9K | -$2.9M | -213.68% | -255.54% | -263.64% | -$2.9M |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
|
LNSR
LENSAR, Inc.
|
$5.8M | -$7.6M | -684.94% | -1013.45% | -52.95% | -$3.5M |
|
MOVE
Movano, Inc.
|
-$200K | -$2.6M | -337.24% | -410.28% | -3238.75% | -$1.6M |
Sight Sciences, Inc. vs. Competitors
-
Which has Higher Returns SGHT or ADGM?
Adagio Medical Holdings, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of --. Sight Sciences, Inc.'s return on equity of -58.45% beat Adagio Medical Holdings, Inc.'s return on equity of -340.49%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M -
What do Analysts Say About SGHT or ADGM?
Sight Sciences, Inc. has a consensus price target of $8.68, signalling upside risk potential of 16.24%. On the other hand Adagio Medical Holdings, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 303.67%. Given that Adagio Medical Holdings, Inc. has higher upside potential than Sight Sciences, Inc., analysts believe Adagio Medical Holdings, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 ADGMAdagio Medical Holdings, Inc.1 0 0 -
Is SGHT or ADGM More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Adagio Medical Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SGHT or ADGM?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Adagio Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. Adagio Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or ADGM?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than Adagio Medical Holdings, Inc. quarterly revenues of --. Sight Sciences, Inc.'s net income of -$8.2M is higher than Adagio Medical Holdings, Inc.'s net income of -$10.1M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while Adagio Medical Holdings, Inc.'s PE ratio is 218.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.07x versus 110.91x for Adagio Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.07x -- $19.9M -$8.2M ADGMAdagio Medical Holdings, Inc.110.91x 218.00x -- -$10.1M
-
Which has Higher Returns SGHT or INBS?
Intelligent Bio Solutions, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of -269.38%. Sight Sciences, Inc.'s return on equity of -58.45% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M INBSIntelligent Bio Solutions, Inc.19.33% -$0.35 $5.4M -
What do Analysts Say About SGHT or INBS?
Sight Sciences, Inc. has a consensus price target of $8.68, signalling upside risk potential of 16.24%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 1021.5%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Sight Sciences, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 INBSIntelligent Bio Solutions, Inc.0 0 0 -
Is SGHT or INBS More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 4.455, suggesting its more volatile than the S&P 500 by 345.491%.
-
Which is a Better Dividend Stock SGHT or INBS?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or INBS?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Sight Sciences, Inc.'s net income of -$8.2M is lower than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.07x versus 21.27x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.07x -- $19.9M -$8.2M INBSIntelligent Bio Solutions, Inc.21.27x -- $1.1M -$3M
-
Which has Higher Returns SGHT or LAB?
Standard BioTools, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of -162.05%. Sight Sciences, Inc.'s return on equity of -58.45% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About SGHT or LAB?
Sight Sciences, Inc. has a consensus price target of $8.68, signalling upside risk potential of 16.24%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 22.05%. Given that Standard BioTools, Inc. has higher upside potential than Sight Sciences, Inc., analysts believe Standard BioTools, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 LABStandard BioTools, Inc.1 2 0 -
Is SGHT or LAB More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.264, suggesting its more volatile than the S&P 500 by 26.42%.
-
Which is a Better Dividend Stock SGHT or LAB?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or LAB?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than Standard BioTools, Inc. quarterly revenues of $19.6M. Sight Sciences, Inc.'s net income of -$8.2M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.07x versus 3.74x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.07x -- $19.9M -$8.2M LABStandard BioTools, Inc.3.74x -- $19.6M -$31.7M
-
Which has Higher Returns SGHT or LNSR?
LENSAR, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of -25.94%. Sight Sciences, Inc.'s return on equity of -58.45% beat LENSAR, Inc.'s return on equity of -1013.45%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M LNSRLENSAR, Inc.40.56% -$0.31 -$9.2M -
What do Analysts Say About SGHT or LNSR?
Sight Sciences, Inc. has a consensus price target of $8.68, signalling upside risk potential of 16.24%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 31%. Given that LENSAR, Inc. has higher upside potential than Sight Sciences, Inc., analysts believe LENSAR, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 LNSRLENSAR, Inc.0 2 0 -
Is SGHT or LNSR More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.695, suggesting its less volatile than the S&P 500 by 30.495%.
-
Which is a Better Dividend Stock SGHT or LNSR?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or LNSR?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than LENSAR, Inc. quarterly revenues of $14.3M. Sight Sciences, Inc.'s net income of -$8.2M is lower than LENSAR, Inc.'s net income of -$3.7M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.07x versus 2.29x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.07x -- $19.9M -$8.2M LNSRLENSAR, Inc.2.29x -- $14.3M -$3.7M
-
Which has Higher Returns SGHT or MOVE?
Movano, Inc. has a net margin of -41.04% compared to Sight Sciences, Inc.'s net margin of -5036.25%. Sight Sciences, Inc.'s return on equity of -58.45% beat Movano, Inc.'s return on equity of -410.28%.
Company Gross Margin Earnings Per Share Invested Capital SGHTSight Sciences, Inc.86.39% -$0.16 $105M MOVEMovano, Inc.-250% -$4.73 $1.5M -
What do Analysts Say About SGHT or MOVE?
Sight Sciences, Inc. has a consensus price target of $8.68, signalling upside risk potential of 16.24%. On the other hand Movano, Inc. has an analysts' consensus of $30.00 which suggests that it could grow by 3756.04%. Given that Movano, Inc. has higher upside potential than Sight Sciences, Inc., analysts believe Movano, Inc. is more attractive than Sight Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SGHTSight Sciences, Inc.3 4 0 MOVEMovano, Inc.0 0 0 -
Is SGHT or MOVE More Risky?
Sight Sciences, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Movano, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SGHT or MOVE?
Sight Sciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Movano, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sight Sciences, Inc. pays -- of its earnings as a dividend. Movano, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SGHT or MOVE?
Sight Sciences, Inc. quarterly revenues are $19.9M, which are larger than Movano, Inc. quarterly revenues of $80K. Sight Sciences, Inc.'s net income of -$8.2M is lower than Movano, Inc.'s net income of -$4M. Notably, Sight Sciences, Inc.'s price-to-earnings ratio is -- while Movano, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sight Sciences, Inc. is 5.07x versus 11.77x for Movano, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SGHTSight Sciences, Inc.5.07x -- $19.9M -$8.2M MOVEMovano, Inc.11.77x -- $80K -$4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
69
RGC alert for Jan 7
Regencell Bioscience Holdings Ltd. [RGC] is up 58.95% over the past day.
Buy
69
WDC alert for Jan 7
Western Digital Corp. [WDC] is down 8.88% over the past day.
Buy
75
DRUG alert for Jan 7
Bright Minds Biosciences, Inc. [DRUG] is up 2.99% over the past day.
